Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Cancer

Drinks That May Reduce Risk Of Head And Neck Cancers: How Much To Drink For Benefits

A recent study revealed a reduced cancer risk among daily coffee and tea drinkers, including head and neck cancers, cancers of the oral cavity, and oropharyngeal cancers.

Medical Daily

King Charles' cancer treatment 'moving in positive direction' and 'will continue into next year'

Royal sources give health update on the King who announced his diagnosis in February

Evening Standard

NHS to get drug which helps prevent hearing loss in children having chemotherapy

Around 60 children and young people each year will benefit from Pedmarqsi.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

A New Dawn in Cancer Treatment: Immunocine Gives Hope Through Its Revolutionary Immunotherapy

Unlike traditional treatments like chemotherapy and radiation, which often harm healthy cells, Immunocine's approach is precise, attacking only the cancerous cells while preserving the body's overall health.

International Business Times

Young Mom Diagnosed With Stage 4 Breast Cancer Weeks After Clear Mammogram Reveals Overlooked Symptoms

The 31-year-old nurse and mother from New Jersey received the news of stage 4 breast cancer diagnosis, weeks after her mammogram cleared her of the disease.

Medical Daily

EPA bans widely used chemicals linked to cancer before Trump takes office

Move to ban TCE and perc, commonly used in everyday products, will make it hard for Trump to undo rules

The Guardian - US

EPA Takes Bold Step to Ban Cancer-Causing Chemicals

The EPA bans trichloroethylene (TCE) and perchloroethylene (PCE), marking a significant step toward protecting public health from cancer-causing chemicals.

Mic

Read news from The Economist, FT, and more,
with one subscription

Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst

Janux Therapeutics reports updated clinical data for JANX007, highlighting significant efficacy, safety, and durability in advanced prostate cancer patients.

Benzinga

Pioneering drug for rare eye cancer gets go-ahead to be offered on NHS

Campaigners welcome Nice approval for use of Kimmtrak (tebentafusp) to treat patients with uveal melanoma

The Guardian - UK

Pharma giant taken to court after breast implant recall

Patients allegedly exposed to a higher cancer risk from 'defective' breast implants that have now been recalled are suing a pharmaceutical firm seeking damages.

AAP

‘Pioneering’ drug for rare eye cancer to be rolled out on NHS in England

New drug avilable on the NHS could boost eye cancer patients’ survival time by months

The Independent UK

Why Is BeiGene Stock Trading Higher On Wednesday?

BeiGene's Tevimbra receives EU approval for advanced ESCC and G/GEJ cancers, showing significant survival benefits in pivotal Phase 3 trials.

Benzinga

Smoking could cause 300,000 cancer cases in UK by 2029, study finds

Cancer Research urges MPs to back tobacco and vapes bill, saying damage caused by cigarettes cannot be ignored

The Guardian - UK

Smoking could cause almost 300,000 cancer cases by 2029, charity says

Cancer Research UK estimates there were nearly 160 cancer cases attributed to smoking diagnosed in the UK every day in 2023.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

The Independent UK

Majority Black Louisiana elementary school to shut down amid lawsuits over toxic air exposure

A southeast Louisiana school board voted to shut down a predominantly Black elementary school next to a petrochemical facility embroiled in multiple lawsuits over its high levels of toxic emissions

The Guardian - UK

Study raises hopes of treating aggressive cancers by zapping rogue DNA

Tumours could be reduced by targeting genetic material driving their growth with a new drug in early-stage trials

Newcastle Herald

'High risk': Melanoma hotspots revealed, as four Hunter areas make top 25

One Hunter area dropped out of the top 25, but one came in.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

OPINION - Let's face it; there are no good contraceptive options

The hormonal coil I use has a breast cancer risk

The Independent UK

‘Deeply concerning’ backlog of thousands of cancer patients waiting months for treatment revealed

‘I have zero faith in the NHS, nothing. I’ve got nothing left,’ says kidney cancer patient left waiting months for diagnosis

Evening Standard

Head and neck cancer cases rising in England, report warns

Experts also highlighted ‘stark inequalities’, with people in the most deprived areas twice as likely to develop head and neck cancer

USA Today Sports Media Group

Chiefs to celebrate cancer survivors on Monday night for Crucial Catch game vs. Saints

Kansas City #Chiefs to celebrate cancer survivors on Monday night for Crucial Catch game vs. New Orleans #Saints | @EdEastonJr

The Guardian - UK

Women in England with ‘worrying’ breast lumps to be referred directly to specialists

Trial forms part of government plans to expedite referrals for patients with cancer symptoms

The Independent UK

Most accurate ultrasound test ‘can detect 96% of women with ovarian cancer’

A new study compared all the tests that are currently available to diagnose the condition.

Evening Standard

Revealed: Areas of London with longest waits for cancer treatment

Treatment targets not met for several cancers in regions of the capital

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Sheffield

43 stories

Target Ovarian Cancer

32 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.